Drug Type Protein drugs |
Synonyms Recombinant diphtheria immunotoxin |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma of Head and Neck | Preclinical | US | 22 Mar 2022 | |
Squamous Cell Carcinoma of Head and Neck | Preclinical | US | 22 Mar 2022 |